iwr-1-endo and Neoplasms

iwr-1-endo has been researched along with Neoplasms* in 3 studies

Reviews

1 review(s) available for iwr-1-endo and Neoplasms

ArticleYear
Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer.
    Journal of medicinal chemistry, 2022, 04-14, Volume: 65, Issue:7

    Tankyrases are multifunctional poly(adenosine diphosphate-ribose) polymerases that regulate diverse biological processes including telomere maintenance and cellular signaling. These processes are often implicated in a number of human diseases, with cancer being the most prevalent example. Accordingly, tankyrase inhibitors have gained increasing attention as potential therapeutics. Since the discovery of XAV939 and IWR-1 as the first tankyrase inhibitors over two decades ago, tankyrase-targeted drug discovery has made significant progress. This review starts with an introduction of tankyrases, with emphasis placed on their cancer-related functions. Small-molecule inhibitors of tankyrases are subsequently delineated based on their distinct modes of binding to the enzymes. In addition to inhibitors that compete with oxidized nicotinamide adenine dinucleotide (NAD

    Topics: Catalytic Domain; Drug Discovery; Humans; Neoplasms; Tankyrases

2022

Other Studies

2 other study(ies) available for iwr-1-endo and Neoplasms

ArticleYear
Development of a penetratin-conjugated stapled peptide that inhibits Wnt/β-catenin signaling.
    Bioorganic & medicinal chemistry, 2022, 11-01, Volume: 73

    Wnt/β-catenin pathway triggers the formation of a complex between β-catenin and T cell-specific transcription factor (TCF), which induces transcriptional activation. Excessive transcriptional activation of this pathway is associated with the development, cause, and deterioration of various cancers. Therefore, the Wnt/β-catenin pathway is an attractive drug target for cancer therapeutics and small molecule- and peptide-based protein-protein interaction (PPI) inhibitors have been developed. However, peptide-based PPI inhibitors generally have low cell-membrane permeability because of their large molecular size. To improve cell-membrane permeability, conjugating cell-penetrating peptides (CPPs) to PPI-inhibiting peptides is a useful method for developing intracellularly targeted PPI inhibitors. In this study, we focused on the interaction between β-catenin and liver receptor homologue-1 (LRH-1) and designed and synthesized a series of LRH-1-derived peptides to develop inhibitors against Wnt/β-catenin signaling. The results showed that a penetratin-conjugated LRH-1-derived peptide (Penetratin-st7) predominantly inhibited DLD-1 cell growth at 20 μM treatment via inhibition of the Wnt signaling pathway. This result suggests that Penetratin-st7 is one of promising PPI inhibitors between TCF and β-catenin.

    Topics: beta Catenin; Cell-Penetrating Peptides; Humans; Neoplasms; TCF Transcription Factors; Wnt Signaling Pathway

2022
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
    Nature chemical biology, 2009, Volume: 5, Issue:2

    The pervasive influence of secreted Wnt signaling proteins in tissue homeostasis and tumorigenesis has galvanized efforts to identify small molecules that target Wnt-mediated cellular responses. By screening a diverse synthetic chemical library, we have discovered two new classes of small molecules that disrupt Wnt pathway responses; whereas one class inhibits the activity of Porcupine, a membrane-bound acyltransferase that is essential to the production of Wnt proteins, the other abrogates destruction of Axin proteins, which are suppressors of Wnt/beta-catenin pathway activity. With these small molecules, we establish a chemical genetic approach for studying Wnt pathway responses and stem cell function in adult tissue. We achieve transient, reversible suppression of Wnt/beta-catenin pathway response in vivo, and we establish a mechanism-based approach to target cancerous cell growth. The signal transduction mechanisms shown here to be chemically tractable additionally contribute to Wnt-independent signal transduction pathways and thus could be broadly exploited for chemical genetics and therapeutic goals.

    Topics: Axin Protein; beta Catenin; Humans; Molecular Structure; Neoplasms; Regeneration; Repressor Proteins; Signal Transduction; Wnt Proteins

2009